NC State Startup Locus Biosciences Lands $19M in Funding for Gene Editing Technology

Locus Biosciences, born with the help of two loans from the North Carolina Biotechnology Center, has raised $19 million in Series A funding from major investors.

The round was led by ARTIS Ventures of San Francisco with additional financing from institutional investors Tencent Holdings Ltd., the Chinese internet conglomerate, Abstract Ventures of San Francisco, and others.